Flerie Invest: Funding, Team & Investors | Startup Intros

Loading organizations...

Flerie Invest: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 8, 2026	KAHR medical	$32.0M Debt / Other Equity	Ted Fjällman, Cancer Focus Fund, Oriella, Peregrine Ventures	SPRIM Global Investments
Feb 9, 2023	Prokarium	$30.0M Other Equity	Thomas Eldered	—
Sep 9, 2022	AnaCardio	$14.1M Series A	Mark Quick, Industrifonden	—
Mar 25, 2022	Geneos Therapeutics	$17.0M Series A	Ted Fjällman	Global Bio Fund, INOVIO Pharmaceuticals, Korea Investment Partners, Sante Ventures
Feb 1, 2022	Microbiotica	$68.0M Series B	Carl-Johan Spak, Tencent	ARCH Venture Partners, Cambridge Innovation Capital, HealthCap, Mubadala, Judith Hartley MBE, Seventure Partners
Dec 16, 2021	Synerkine Pharma	$4.0M Series A Extension	Ted Fjällman	Thuja Capital, Utrecht Holdings
Aug 18, 2021	EpiEndo Pharmaceuticals	$23.5M Series A	Carl-Johan Spak, hilmar janusson	Ivar Gudjonsson, European Innovation Council
Oct 1, 2020	Prokarium	$21.0M Series B	Korea Investment Partners	Future Fund, Riyadh Valley Company
Feb 25, 2020	KAHR medical	$18.0M Other Equity	Flerie Invest, Hadasit Bio-Holdings, Mirae Asset Venture Investment, Oriella, Pavilion Capital	—
Feb 1, 2018	Prokarium	$10.0M Series A	Khalid Al-Saleh	Korea Investment Partners, Thomas Eldered
Dec 15, 2015	KAHR medical	$12.0M Series B	—	Korea Investment Partners, DSC Investment, Mirae Asset Venture Investment